COMP <GO>
ALLR vs DARE // EV/EBITDA & P/E VALUATION
Allarity Therapeutics Inc. (NASDAQ) VS. Dare Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: ALLR 1
— DARE 2
■ METRIC PARITY
LAST: $0.89 (-6.32%) • MKT CAP: $14.2M
valuation
—
LAST: $0.68 (+0.22%) • MKT CAP: $13.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALLR VS. DARE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALLR | DARE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 71.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 180.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | DARE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.9 | 42.9 | -4.03 | DARE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.2M | $13.4M | $756.1K | ALLR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALLR REV | DARE REV | ALLR GROSS % | DARE GROSS % | ALLR FCF | DARE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.0M | — | 71.3% | -$14.8M | -$10.3M |
| FY 2024 | $0 | $9.8K | — | 98.0% | -$17.6M | $4.9M |
| FY 2023 | $0 | $2.8M | — | — | -$12.7M | -$38.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALLR // BETA —
DARE // BETA —